A federal grand jury in San Francisco returned an indictment yesterday charging a California company for its participation in a years-long scheme to illegally distribute Adderall over the internet, conspire to commit healthcare fraud in connection with the submission of false and fraudulent claims for reimbursement for Adderall and other stimulants, and conspire to obstruct justice. A Florida medical practice was also charged in connection with its alleged participation in the scheme to illegally distribute Adderall.